IL-1α and colorectal cancer pathogenesis: Enthralling candidate for anti-cancer therapy

Crit Rev Oncol Hematol. 2021 Jul:163:103398. doi: 10.1016/j.critrevonc.2021.103398. Epub 2021 Jun 18.

Abstract

Inflammation has been well-established as a hallmark of colorectal cancer (CRC). Interleukin-1 alpha (IL-1α) is one of the primary inflammatory mediators driving the pathogenesis of inflammation-associated CRC. This systematic review presents the roles of IL-1α in the pathogenesis of the disease. Bibliographic databases PubMed, Science Direct, Scopus and Web of Science were systematically searched for articles that addresses the relationship between IL-1α and colorectal cancer. We highlighted various mechanisms by which IL-1α promotes the pathogenesis of CRC including enhancement of angiogenesis, metastasis, resistance to therapy, and inhibition of tumour suppressive genes. We also discussed the potential mechanisms by which IL-1α expression is induced or secreted in various studies. Beyond these, the systematic review also highlights several potential therapeutic strategies which should be further explored in the future; to target IL-1α and/or its associated pathways; paving our way in finding effective treatments for CRC patients.

Keywords: Cancer; Colorectal cancer; Cytokine; DAMP; Inflammation; Interleukin-1 alpha; Metastasis; Targeted therapy.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Colorectal Neoplasms* / drug therapy
  • Colorectal Neoplasms* / etiology
  • Humans
  • Inflammation
  • Interleukin-1alpha* / genetics
  • Neovascularization, Pathologic / drug therapy

Substances

  • Interleukin-1alpha